

A practical guide for providers on helping patients locate Clomipramine during the ongoing shortage. Tools, workflows, and clinical strategies.
When patients call your office saying they cannot fill their Clomipramine (Anafranil) prescription, it creates a cascade of problems. They are anxious about running out. Your staff spends time on the phone with pharmacies. And if the medication truly cannot be found, you face a clinical decision about switching a stable OCD patient to a new regimen.
This guide provides a practical, step-by-step workflow for helping patients locate Clomipramine during the ongoing shortage, along with clinical strategies for when the medication simply cannot be found.
Clomipramine has been subject to intermittent supply disruptions since 2020. The shortage is driven by limited generic manufacturers, global supply chain constraints, and the relatively small production volume of this niche TCA. Brand-name Anafranil is largely discontinued in the US.
For a detailed clinical overview of the shortage, causes, and switching protocols, see our companion article: Anafranil shortage: What providers and prescribers need to know in 2026.
Do not wait for patients to call you in a panic. Run a report in your EHR to identify all patients currently prescribed Clomipramine. For each patient:
A proactive 5-minute phone call or patient portal message can prevent a treatment crisis. Consider language like: "We know Clomipramine has been hard to find at some pharmacies. We want to make sure you have a plan for your next refill. Please let us know if you have any trouble, and we can help."
Medfinder for Providers allows your office staff to search for pharmacies with Clomipramine currently in stock. This is far more efficient than calling individual pharmacies.
Here is how to integrate it into your workflow:
This process typically takes less than 10 minutes and can save the patient days of searching.
Shortages often affect specific strengths rather than all formulations. Clomipramine is available in 25 mg, 50 mg, and 75 mg capsules. Before switching medications, check whether the patient's dose can be achieved with a different capsule combination:
| Patient Dose | Standard Rx | Alternative Combinations |
|---|---|---|
| 75 mg/day | 1 × 75 mg | 3 × 25 mg or 1 × 50 mg + 1 × 25 mg |
| 100 mg/day | 1 × 75 mg + 1 × 25 mg | 2 × 50 mg or 4 × 25 mg |
| 150 mg/day | 2 × 75 mg | 3 × 50 mg or 6 × 25 mg |
| 200 mg/day | Various | 4 × 50 mg or 2 × 75 mg + 1 × 50 mg |
| 250 mg/day | Various | 5 × 50 mg or 10 × 25 mg |
Rewriting the prescription for an available strength is often the quickest solution and avoids the need for a medication switch entirely.
If standard retail pharmacies are out of stock, consider these alternatives:
Independent pharmacies may use different wholesalers than chain pharmacies and sometimes have access to stock that chains do not. They are often more willing to special-order a medication and hold it for a specific patient.
Compounding pharmacies can prepare Clomipramine from raw active pharmaceutical ingredients. This requires a compounding-specific prescription. While more expensive (and may not be covered by insurance), it can bridge a gap when commercial formulations are unavailable.
Mail-order pharmacies and specialty pharmacies often maintain larger inventories. They may have stock when local pharmacies do not. If the patient's insurance offers mail-order benefits, this is worth exploring, especially for 90-day supplies.
If your practice is affiliated with a hospital or health system, check whether the system pharmacy can fill outpatient prescriptions. Health system pharmacies sometimes have different supply channels.
Reduce the frequency of shortage encounters by writing for the largest supply the patient's insurance allows — typically 90 days for mail-order. Benefits include:
If the insurer requires prior authorization for a 90-day supply, submit it proactively. Include a note that the patient is on a medication subject to ongoing shortage and a larger supply is clinically necessary to prevent treatment interruptions.
If you have exhausted all options and the patient cannot obtain Clomipramine, you will need to transition them to an alternative. For detailed switching protocols and evidence-based alternative recommendations, see our clinical guide: Anafranil shortage: What providers and prescribers need to know in 2026.
Key principles for the transition:
Patients dealing with the shortage are often anxious and frustrated. Clear communication helps:
As a provider, you have a voice in the broader conversation about drug shortages. Consider:
The Clomipramine shortage is frustrating for patients and providers alike. But with proactive planning, the right tools, and clear clinical protocols, you can help your patients maintain treatment continuity — even when the supply chain falls short.
For real-time inventory data and provider tools, visit Medfinder for Providers. For the latest shortage updates, see our 2026 clinical shortage update.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.